Veracyte (VCYT) Tops Q2 EPS by 5c, Revenues Beat; Raises FY19 Revenue Guidance
Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.05), $0.05 better than the analyst estimate of ($0.10). Revenue for the quarter ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
